PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition

Pulmonary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1997, Pages 157-166

  Webber, S E ^a,b   Kitt, A ^a   Yurdakos, E ^a,c   Widdicombe, J G ^a,d  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b SANOFI   (France)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Albumin; Bradykinin; Lysozyme; Nedocromil sodium; PAF; Trachea

Indexed keywords

ALBUMIN; APAFANT; BRADYKININ; CATALASE; LYSOZYME; NEDOCROMIL SODIUM; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; FEMALE; FERRET; MALE; NONHUMAN; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; PROTEIN SECRETION; TRACHEA;

EID: 0031172920     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1997.0089     Document Type: Article

References (33)

1. 1. Bertrand M, Geppetti P. Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic airway disease. TIPS 1996; 17: 25-259.
2. 2. Pretojani M, Vergaftig B B. Platelet activating factor as a mediator of allergic diseases. In: Busse W W, Holgate S T eds. Asthma and Rhinitis. Oxford: Blackwell Scientific Publications, 1995: 884-894.
3. 3. Kuitert L M, Angus R M, Barnes N C, Barnes P J, Bone M F, Chung K F, Fairfax A J, Higenbotham T W, O'Conner B J, Piotrowska B, Rozniecki J, Uden S, Walters E H, Willard C J. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am J Respir Crit Care Med 1995; 151: 1331-1335.
4. 4. Spence D P, Johnston S L, Calverley P M, Dhillon P, Higgins C, Ramhamadang E, Turner S, Winning A, Winter J, Holgate S J. The effects of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149: 1142-1148.
5. 5. Cuss F M, Dixon C M S, Barnes P J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; ii: 189-192.
6. 6. Fuller R W, Dixon C M S, Cuss F M, Barnes P J. Bradykinin-induced bronchoconstriction in man. Am Rev Respir Dis 1987; 135: 176-180.
7. 7. Corfield D R, Webber S E, Hanafi Z, Widdicombe J G. The actions of bradykinin and lys-bradykinin on tracheal blood flow and smooth muscle in anaesthetized sheep. Pulm Pharmacol 1991; 4: 85-90.
8. 8. Corfield D R, Webber S E, Widdicombe J G. Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow. Br J Pharmacol 1991; 103: 1740-2744.
9. 9. Evans T W, Chung K F, Rogers D F, Barnes P J. Effect of platelet activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 1987; 63: 479-484.
10. 10. Rogers D F, Dijk S, Barnes P J. Bradykinin-induced plasma exudation in guinea pig airways: involvement of platelet activating factor. Br J Pharmacol 1990; 101: 739-745.
11. 11. Sasaki T, Shimura S, Ikeda K, Sasaki H, Takishima T. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal glands. Am J Physiol 1989; 257: L373-L378.
12. 12. Adler K B, Schwartz J E, Anderson W H, Welton A F. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. Eur J Pharmacol 1987; 142: 367-372.
13. 13. Goswani S K, Lhashi M, Stathas P, Marom Z M. Platelet activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture. J Allergy Clin Immunol 1989; 84: 726-734.
14. 14. Goswani S K, Ohashi M, Pangiotis S, Marom Z. Platelet activating factor enhances mucous glycoprotein release from human airways in vitro. Am Rev Respir Dis 1987; 135: A159.
15. 15. Hahn H L, Lang M, Sannwald V, Stenzel H. Effects of platelet activating factor on release of mucus from tracheal submucosal glands in the ferret. Am Rev Respir Dis 1985; 131: A27.
16. 16. Webber S E, Morikawa T, Widdicombe J G. PAF-induced muscarinic cholinoceptor hyperresponsiveness of ferret tracheal smooth muscle and gland secretion in vitro. Br J Pharmacol 1992; 105: 230-237.
17. 17. Wells U M, Yurdakos E, Kitano S, Webber S E, Widdicombe J G. The effects of indomethacin and thiorphan on bradykinin-induced albumin output and submucosal gland secretions in the ferret trachea in vivo. Pulm Pharmacol 1993; 6: 137-142.
18. 18. Baker A P, Hillegass L M, Holden D A, Smith W J. Effect of kallidin, substance P, and other basic polypeptides on the production of respiratory macromolecules. Am Rev Respir Dis 1997; 115: 811-817.
19. 19. Tamaoki J, Kobayashi K, Sakai N, Chiyotani A, Kanemura Y, Takizawa T. Effect of bradykinin on airway ciliary motility and its modulation by neutral endopeptidase. Am Rev Respir Dis 1989; 140: 430-435.
20. 20. Webber S E, Widdicombe J G. The transport of albumin across the ferret in vitro trachea. J Physiol 1989; 408: 457-472.
21. 21. Webber S E, Widdicombe J G. The effect of VIP on smooth muscle tone and mucus secretion from the ferret trachea. Br J Pharmacol 1987; 91: 139-148.
22. 22. Steiger J, Bray M A, Subramanian N. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. Eur J Pharmacol 1987; 142: 367-372.
23. 14C]antipyrine. J Appl Physiol 1994; 77: 1263-1273.
24. 24. Rogers D F, Alton E W F W, Aursudkij B, Boschetto P, Dewar A, Barnes P J. Effect of platelet activating factor on formation and composition of airway fluid in the guinea pig trachea. J Physiol 1990; 431: 643-658.
25. 25. Baraniuk J N, Lundgren J D, Mizoguchi H, Peden D, Gawin A, Merida M, Shelhamer J H, Kaliner M A. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis 1990; 141: 706-714.
26. 26. Yamaha M, Finkbeiner W E, Widdicombe J H. Ion transport by cultures of human tracheobronchial submucosal glands. Am J Physiol 1991; 261: L485-L490.
27. - secretion via two second messenger pathways. Am J Physiol 1990; 258: L369-L377.
28. 28. Morikawa T, Webber S E, Widdicombe J G. The effect of hydrogen peroxide on smooth muscle tone, mucus secretion and epithelial albumin transport of the ferret trachea in vitro. Pulm Pharmacol 1991; 2: 106-113.
29. 29. Morikawa T, Webber S E, Widdicombe J G. Platelet activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro. Br J Pharmacol 1992; 105: 223-229.
30. 30. Mattoli S, Mezzetti M, Fasoli A, Patalano F, Allegra L. Nedocromil sodium prevents the release of 15-hydroxyeicosatetraenoic acid from human bronchial epithelial cells exposed to toluene diisocyanate in vitro. Int Arch Allergy Appl Immunol 1990; 92: 16-22.
31. 31. Marini M, Soloperto M, Zheng Y, Mezzetti M, Mattoli S. Protective effect of nedocromil sodium on the IL1-induced release of GM-CSF from cultured human bronchial epithelial cells. Pulm Pharmacol 1992; 5: 61-65.
32. 32. Rubin R P, Thompson R H, Naps M S. Differential inhibition by nedocromil sodium of Superoxide generation by platelet activating factor in human neutrophils. Agents & Actions 1990; 31: 237-242.
33. 33. Barnes P J, Holgate S T, Laitinen L A, Pauwels R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exper Allergy 1995; 25: 771-787.